Nine more pharmaceutical manufacturers join Trump's most-favored-nation initiative
(The Center Square) – Nine more companies have joined President Donald Trump’s most-favored-nation drug pricing agreement, one of the president’s most highly publicized affordability initiatives to bring down the cost of prescription drugs.